We are live on
!
Find out more
HA
HHLR Advisors Portfolio holdings
AUM
$832M
1-Year Est. Return
32.38%
This Fund
S&P 500
This Quarter
Est. Return
-15.01%
1 Year Est. Return
+32.38%
3 Year Est. Return
+137.31%
5 Year Est. Return
+86.76%
10 Year Est. Return
–
AUM
$2.41B
AUM Growth
–
Cap. Flow
+$2.47B
Cap. Flow
% of AUM
102.3%
Top 10 Holdings %
Top 10 Hldgs %
82.56%
Holding
32
New
32
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ONC
BeOne Medicines Ltd
ONC
|
+$589M |
| 2 |
JD.com
JD
|
+$337M |
| 3 |
Alibaba
BABA
|
+$209M |
| 4 |
CBPO
China Biologic Products Holdings, Inc.
CBPO
|
+$202M |
| 5 |
TAL Education Group
TAL
|
+$198M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 50.9% |
| 2 | Consumer Discretionary | 22.72% |
| 3 | Consumer Staples | 15.78% |
| 4 | Communication Services | 10.51% |
| 5 | Real Estate | 0.09% |
Similar funds
ACGDR
NCM
SIG
AFA
BEC
AFA
BCG
AWA
HHLR Advisors's Q4 2018 Portfolio in Review
Q4 2018 is the first quarter with a 13F filing on record for HHLR Advisors, which disclosed 32 positions worth $2.41B. Its ten largest holdings account for 83% of the portfolio.
Its largest position is BeOne Medicines Ltd: 4,437,953 shares worth $622M.
By sector, the portfolio is most concentrated in Healthcare at 51% of assets, followed by Consumer Discretionary and Consumer Staples.
- HHLR Advisors's largest Q4 2018 buy was BeOne Medicines Ltd: 4,437,953 shares worth $622M.
- HHLR Advisors's ten largest holdings make up 83% of its $2.41B portfolio in Q4 2018.
- HHLR Advisors disclosed 32 positions in Q4 2018, its first 13F filing on record.
Based on HHLR Advisors's 13F filing for Q4 2018, filed 14 Feb 2019.